Evidence map›Paper›PMID 37035968›Full record

ArticleThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2023

Identifying phenotypes in interstitial lung disease using group-based trajectory modelling.

S Takata, S Komukai, T Hoshino, H Tabuchi, K Masuhiro, M Yaga, Y Shirai, Y Mitsui, Y Abe, T Kuge and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

S TakataDepartments of 1Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
S KomukaiIntegrated Medicine Biomedical Statistics, Osaka University Graduate School of Medicine, Osaka, Japan.
T HoshinoClinical Laboratory, Kakogawa Central City Hospital, Kakogawa, Japan.
H TabuchiLaboratory for Clinical Investigation, Osaka University Hospital, Osaka, Japan.
K MasuhiroDepartments of 1Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
M YagaDepartments of 1Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
Y ShiraiDepartments of 1Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
Y MitsuiDepartments of 1Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
Y AbeDepartments of 1Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
T KugeDepartments of 1Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
K FukushimaDepartments of 1Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan.
H KidaDepartments of 1Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan, Department of Respiratory Medicine, National Hospital Organization Osaka Toneyama Medical Center, Osaka, Japan.
A KumanogohDepartments of 1Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Osaka, Japan, Department of Immunopathology, World Premier International Research Center Initiative, Immunology Frontier Research Center, Osaka, Japan, Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka, Japan, Center for Infectious Disease for Education and Research, Osaka, Japan, Japan Agency for Medical Research and Development - Core Research for Evolutional Science and Technology (AMED-CREST), Osaka, Japan, Center for Advanced Modalities and DDS (CAMaD), Osaka University, Osaka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Lung Diseases, InterstitialHumansLungPhenotype

Identifiers

PMID37035968
PMCPMC10094054

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.